Breslin Cancer Center

Lansing, Michigan 48910

0 studies enrolling now · 6 studies all time

What they study most

Advanced Solid Tumor, Breast Cancer, Breast Neoplasms, Non-Small Cell Lung Cancer, Stage III (IIIB or IIIC) Colon Cancer

Studies at this site

• A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer — Running, not enrolling
• A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE) — Completed
• A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer — Stopped early
• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• M6620 First in Human Study — Completed
• Home-Based Symptom Management Via Reflexology for Breast Cancer Patients — Completed